[go: up one dir, main page]

NO20085214L - Nye pyridinanaloger - Google Patents

Nye pyridinanaloger

Info

Publication number
NO20085214L
NO20085214L NO20085214A NO20085214A NO20085214L NO 20085214 L NO20085214 L NO 20085214L NO 20085214 A NO20085214 A NO 20085214A NO 20085214 A NO20085214 A NO 20085214A NO 20085214 L NO20085214 L NO 20085214L
Authority
NO
Norway
Prior art keywords
pyridine analogs
new pyridine
formula
analogs
new
Prior art date
Application number
NO20085214A
Other languages
English (en)
Inventor
Fabrizio Giordanetto
Johan Johansson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20085214L publication Critical patent/NO20085214L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Formel ( I ) Foreliggende oppfinnelse angår visse nye pyridinanaloger med formel ( I ) til prosesser for fremstilling av slike forbindelser, til deres anvendelse som P2Y12 inhibitorer og som anti-trombotiske midler etc, anvendelse av dem som medikamenter i kardiovaskulære sykdommer og som farmasøytiske preparater inneholdende dem.
NO20085214A 2006-07-04 2008-12-15 Nye pyridinanaloger NO20085214L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601464 2006-07-04
PCT/SE2007/000643 WO2008004943A1 (en) 2006-07-04 2007-07-02 New pyridine analogues

Publications (1)

Publication Number Publication Date
NO20085214L true NO20085214L (no) 2009-01-14

Family

ID=38894822

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085214A NO20085214L (no) 2006-07-04 2008-12-15 Nye pyridinanaloger

Country Status (13)

Country Link
US (2) US20090286834A1 (no)
EP (1) EP2044024A4 (no)
JP (1) JP2009542643A (no)
KR (1) KR20090020712A (no)
CN (1) CN101511792A (no)
AU (1) AU2007270083A1 (no)
BR (1) BRPI0713400A2 (no)
CA (1) CA2656597A1 (no)
IL (1) IL195981A0 (no)
MX (1) MX2008016562A (no)
NO (1) NO20085214L (no)
WO (1) WO2008004943A1 (no)
ZA (1) ZA200810644B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006204159A1 (en) * 2005-01-06 2006-07-13 Astrazeneca Ab Novel pyridine compounds
KR20080039405A (ko) * 2005-07-13 2008-05-07 아스트라제네카 아베 신규한 피리딘 유사체
TW200815426A (en) * 2006-06-28 2008-04-01 Astrazeneca Ab New pyridine analogues II 333
KR20090036573A (ko) * 2006-07-04 2009-04-14 아스트라제네카 아베 신규한 피리딘 유사체
TW200811133A (en) * 2006-07-04 2008-03-01 Astrazeneca Ab New pyridine analogues III 334
KR20090031605A (ko) * 2006-07-04 2009-03-26 아스트라제네카 아베 신규한 피리딘 유사체
AR064867A1 (es) * 2007-01-12 2009-04-29 Astrazeneca Ab Analogos de piridina viii 518
TW200833333A (en) * 2007-01-12 2008-08-16 Astrazeneca Ab New pyridine analogues
US20080171732A1 (en) * 2007-01-12 2008-07-17 Astrazeneca Ab New Pyridine Analogues IX 519
AR064865A1 (es) * 2007-07-13 2009-04-29 Astrazeneca Ab Derivados de piridina antagonistas de p2y12
WO2012174013A2 (en) * 2011-06-14 2012-12-20 Cardeus Pharmaceuticals, Inc. Treatment of cardiovascular disease, stroke, and inflammatory conditions
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
UY38885A (es) * 2019-09-20 2021-04-30 Syngenta Crop Protection Ag Compuestos de azetidinil-, pirrolidinil-,piperdinil- o piperazinil-piridinil carbonilo pesticidamente activos

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
US6906063B2 (en) * 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
JP4574100B2 (ja) * 2000-02-04 2010-11-04 ポートラ ファーマシューティカルズ， インコーポレイテッド 血小板ａｄｐレセプターインヒビター
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7018985B1 (en) * 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
FR2820057A1 (fr) * 2001-01-30 2002-08-02 Ct De Transfert De Technologie Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane
US7335648B2 (en) * 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7504497B2 (en) * 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) * 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
BRPI0512535A (pt) * 2004-06-24 2008-03-25 Incyte Corp compostos de piperidinas n-substituìdas, suas composições e métodos de modulações
WO2006035967A1 (en) * 2004-09-30 2006-04-06 Taisho Pharmaceutical Co., Ltd. Pyridine derivatives and their use as medicaments for treating diseases related to mch receptor
KR20090031605A (ko) * 2006-07-04 2009-03-26 아스트라제네카 아베 신규한 피리딘 유사체
KR20090036573A (ko) * 2006-07-04 2009-04-14 아스트라제네카 아베 신규한 피리딘 유사체

Also Published As

Publication number Publication date
AU2007270083A1 (en) 2008-01-10
EP2044024A4 (en) 2011-06-29
KR20090020712A (ko) 2009-02-26
US20080045494A1 (en) 2008-02-21
CN101511792A (zh) 2009-08-19
BRPI0713400A2 (pt) 2012-04-17
US20090286834A1 (en) 2009-11-19
ZA200810644B (en) 2010-01-27
EP2044024A1 (en) 2009-04-08
JP2009542643A (ja) 2009-12-03
CA2656597A1 (en) 2008-01-10
MX2008016562A (es) 2009-02-06
WO2008004943A1 (en) 2008-01-10
IL195981A0 (en) 2009-09-01

Similar Documents

Publication Publication Date Title
NO20085218L (no) Nye pyridinanaloger
NO20085214L (no) Nye pyridinanaloger
NO20085212L (no) Nye pyridinanaloger
NO20085213L (no) Nye pyridinanaloger
NO20076682L (no) Nye pyridinanaloger
NO20073101L (no) Nye pyridinforbindelser
NO20071504L (no) Pyrimidinderivanter.
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
NO20090783L (no) Pyrimidonforbindelser som inhibitorer av GSK-3
NO20090835L (no) Nye HIV-reverstranskriptaseinhibitorer
NO20084202L (no) 4-anilinoquinolin-3-carboksamider som CSF-1R kinase inhibitorer
NO20074592L (no) Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20074634L (no) Substituerte heterocykler og deres anvendelse som CHK1-, PDK1- og PAK-inhibitorer
NO20084712L (no) Nye farmasoytiske forbindelser
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
WO2008144346A3 (en) Crystal structures of sglt2 inhibitors and processes for their preparation
NO20063449L (no) Substituerte heterocykler og deres anvendelse
NO20074258L (no) Pyridin-2-karboksamidderivater som MGLUR5 antagonister
MY148634A (en) Pyridazinone derivatives
NZ577916A (en) Cyclopamine analogs
NO20090295L (no) Substituerte heteroarylderivater
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20071245L (no) Kinazolinonderivater og deres anvendelse som b-RAF-inhibitorer.
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application